Among these, GSE32894, GSE32548, and GSE31684 showed a lower OS for BLCA patients with higher EIF4A3 expression (HR =4.72, p < 0.001, HR =2.72, p = 0.017, HR =1.77, p = 0.033 respectively) (Figs. 3C–3E). This evidence concerns the gene EIF4A3 and bladder transitional cell carcinoma.